KREMPA DAVID (Chief Business Officer) sold 40.3% of their position (25K shares) of ETON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.63M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/24/2026ACC: 0001437749-26-028846
Officer· Chief Business Officer
Since Mar 2023
-25K
Net shares
Net seller
$1.63M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
25K acquired · 50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25K
Price / share
$7.31
Trade value
$182.75K
% of position
67.5%
8/24/2026
37.02K→62.02K
Common Stock
Direct
Shares
−25K
Price / share
$65.07
Trade value
$1.63M
% of position
40.3%
8/24/2026
62.02K→37.02K
Total
Net shares
+0.00
Net value
-$1.44M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/24/2026 | M · Option Exercise | +25K | $7.31 | $182.75K | 67.5% | 37.02K | 62.02K |
| Common Stock Direct | 8/24/2026 | S · Sale | −25K | $65.07 | $1.63M | 40.3% | 62.02K | 37.02K |
| Total | +0.00 | -$1.44M | ||||||
Derivative Transactions1
Employee Stock Option
Direct
Converts to
Common Stock
25K shares
Shares
−25K
Strike price
7.31
Held after
70K
Exercisable
—
8/24/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option Direct | Common Stock25K shares | 8/24/2026 | M · Option Exercise | −25K | 7.31 | — | 70K |